Allergan has reported lower sales in both the fourth-quarter and full-year 2018 periods. Fourth-quarter revenues of $4.08 billion represented a 5.7 percent drop from the same quarter a year ago. Full-year 2018 revenues of $15.79 billion marked a 1 percent decrease from 2017. The company said that its core business ...
Buying a membership today will give you:
To continue reading this article register now.